血液恶性瘤中的双特异性抗体:攻击前线
Toral Shastri1, Asaad Trabolsi2,3, Artavazd Arumov2,3
1Internal Medicine Residency Program, University of Miami Miller School of Medicine, Miami, FL, USA.
概括
双特异性抗体 (BsAbs) 正在彻底改变血液癌症的治疗方法,在淋巴细胞恶性瘤和多发性髓瘤中取得了成功. 目前正在进行的试验正在探索它们的治疗潜力,特别是在早期的治疗线上.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 血液学 血液学 血液学
背景情况:
- 双特异性抗体 (BsAbs) 代表了癌症治疗的重大进展,特别是在淋巴细胞恶性瘤中.
- 布利纳图莫马布是第一个经批准的BsAb,已从复发性治疗转变为B细胞急性淋巴细胞白血病 (B-ALL) 的一线治疗.
研究的目的:
- 审查双特异性抗体在治疗血液性恶性瘤中的当前情况和未来潜力.
- 突出BsAbs在B细胞非霍奇金淋巴瘤和多发性骨髓瘤 (MM) 的成功.
主要方法:
- 审查FDA批准的双特异性抗体及其临床应用.
- 分析正在进行和未来的临床试验,调查BsAb组合和早期的线路治疗.
主要成果:
- 另外六种BsAbs被FDA批准用于B细胞淋巴瘤和MM,在耐火病例中显示出高响应率.
- 埃普科里他马布,格洛菲他马布和莫苏努祖马布在淋巴瘤中显示出无化疗缓解的前景.
- 德基利斯塔马布,塔尔克塔马布和埃拉拉纳塔马布在复发性MM中实现了高完全缓解率 (CR),并且正在早期环境中进行研究.
结论:
- BsAbs在血液恶性瘤中非常有效,提供新的治疗选择.
- 组合疗法和BsAbs的早期线路治疗对实现持久缓解和潜在治愈具有重大前景.
- BsAbs被定位为成为各种血液癌症的前线治疗方法.
相关概念视频
01:31Hybridoma Technology
15.3K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.3K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
01:36Humoral Immune Responses
76.1K
Overview
76.1K